Yesterday LifeScan, now a privately held company free from the clutches of JNJ, made the following announcement;
“LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch® brand, today announced it has entered into an exclusive agreement with Sanvita Medical, LLC, to market continuous glucose monitoring (CGM) sensors. Sanvita Medical is a subsidiary of Nova Biomedical Corporation, a world leader focused on accuracy and dependability in advanced technology blood testing analyzers and blood glucose monitoring.”
At first glance you start thinking yep another Dexcom wannabe coming to market late in the game meaning the only . . .
This content is restricted to subscribers. Please subscribe.
Already have an account? Please login.